The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway.
Ebola virus (EBOV) expresses three different glycoproteins (GPs) from its GP gene. The primary product, soluble GP (sGP), is secreted in abundance during infection. EBOV sGP has been discussed as a potential pathogenicity factor, however, little is known regarding its functional role. Here, we analy...
Guardado en:
Autores principales: | Wakako Furuyama, Kyle Shifflett, Heinz Feldmann, Andrea Marzi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cc83fff300b74ca9a612f028f74f0da2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo.
por: Allison Groseth, et al.
Publicado: (2012) -
A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry
por: J. Maximilian Fels, et al.
Publicado: (2019) -
Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies
por: Vincent Madelain, et al.
Publicado: (2018) -
Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing
por: Punya Shrivastava-Ranjan, et al.
Publicado: (2018) -
Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine.
por: Joseph E Blaney, et al.
Publicado: (2013)